Active, not recruitingNCT04798625
Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication
Studying Autoimmune hepatitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Diakonhjemmet Hospital
- Enrollment
- 2300 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2027
Study locations (2)
- Akershus University Hospital, Lørenskog, Norway
- Diakonhjemmet Hospital, Oslo, Norway
Collaborators
University Hospital, Akershus
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04798625 on ClinicalTrials.govOther trials for Autoimmune hepatitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07378202Machine Learning for Prediction of Therapy Response in Autoimmune HepatitisHannover Medical School
- RECRUITINGPHASE2NCT06381453Belimumab in Autoimmune HepatitisUniversity Health Network, Toronto
- RECRUITINGPHASE1NCT06455280A Study of SIPLIZUMAB in AILD and LT PatientsElizabeth C. Verna
- ENROLLING BY INVITATIONNCT06061341TruGraf Liver Gene Expression Serial TestWashington University School of Medicine
- RECRUITINGNCT06519162Liver-gut Axis Study Through Identification of Liver Disease-specific MicrobiomeChungnam National University Hospital
- RECRUITINGNANCT06250309Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis PatientsIndiana University
- RECRUITINGNCT05810480PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin GHannover Medical School
- RECRUITINGNCT06078098Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample StorageUniversity of Milano Bicocca